Form 4 for SER Serina Therapeutics, Inc.
Accepted 2025-04-01 00:00:00 ET · period of report 2025-03-28 · accession 0001628280-25-015888 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-01 | 2025-03-28 | SER | LEDGER STEVEN A | CEO, Dir | J - Other | $0.00 | +95.7K | 95.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-28 | J | A | 95,730 | $0.00 | 95,730 | D | — | — | (F2) In prior reports, the Reporting Person reported beneficial ownership of 227,927 shares of the Issuers common stock held by Ki Partners LLC. |